| __timestamp | Telix Pharmaceuticals Limited | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22622695 | 3243000 |
| Thursday, January 1, 2015 | 24863028 | 2472000 |
| Friday, January 1, 2016 | 21351001 | 2548000 |
| Sunday, January 1, 2017 | 53837297 | 19623000 |
| Monday, January 1, 2018 | 16080096 | 30421000 |
| Tuesday, January 1, 2019 | 18525736 | 32793999 |
| Wednesday, January 1, 2020 | 2024000 | 28304000 |
| Friday, January 1, 2021 | 2548000 | 620000 |
| Saturday, January 1, 2022 | 61556000 | 755000 |
| Sunday, January 1, 2023 | 188157000 | 1322000 |
Unleashing the power of data
In the dynamic world of biotechnology, understanding financial health is crucial. This analysis delves into the cost of revenue trends for Telix Pharmaceuticals Limited and Viridian Therapeutics, Inc. over the past decade. Telix Pharmaceuticals has shown a remarkable increase in its cost of revenue, peaking in 2023 with a staggering 188 million, a growth of over 700% from 2014. This surge reflects their aggressive expansion and investment in research and development. In contrast, Viridian Therapeutics experienced a more volatile journey, with its cost of revenue peaking in 2019 at 32.8 million, before dropping significantly in subsequent years. This fluctuation could indicate strategic shifts or market challenges. The data highlights the contrasting financial strategies and market responses of these two companies, offering valuable insights for investors and industry analysts alike.
AstraZeneca PLC vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Viridian Therapeutics, Inc.
Cost of Revenue Comparison: Exelixis, Inc. vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Viridian Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Amneal Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Vericel Corporation
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Viridian Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Viridian Therapeutics, Inc. vs MiMedx Group, Inc.